The National Toxicology Program evaluation of genetically altered mice as predictive models for identifying

W C Eastin1, J K Haseman, J F Mahler

  • 1National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709-2233, USA. Eastin@niehs.nih.gov

Toxicologic Pathology
|August 26, 1998
PubMed

Insights

Genetically altered mouse models show promise for faster, cheaper carcinogen identification. Tg.AC and p53+/- mice may improve chemical safety testing and risk assessment strategies.

Area of Science:

  • Toxicology
  • Genetics
  • Carcinogenesis

Background:

  • Researchers are investigating genetically altered mice for studying cancer mechanisms.
  • Two models, Tg.AC and p53+/-, exhibit accelerated chemically induced tumors.
  • These models are proposed for novel carcinogen identification and risk assessment strategies.

Purpose of the Study:

  • To evaluate the utility of Tg.AC and p53+/- genetically altered mouse models for identifying chemical carcinogens.
  • To assess the strengths and weaknesses of these models compared to traditional rodent assays.
  • To determine if these models can serve as rapid and cost-effective testing systems.

Main Methods:

  • Tg.AC and p53+/- mice were tested with 11 chemicals.
  • Chemical candidates were selected from the National Toxicology Program (NTP) historical database and open literature.
  • Results were compared with traditional 2-year rodent carcinogenicity assays and human tumor data.

Main Results:

  • The study evaluated 11 chemicals in Tg.AC and p53+/- mice.
  • Initial findings suggest these models can identify known rodent and human carcinogens.
  • Results support the potential of these models as efficient screening tools.

Conclusions:

  • Genetically altered mouse models demonstrate potential for enhanced carcinogen identification.
  • These models may offer a more rapid and economical approach to chemical safety assessment.
  • Further studies are warranted to fully establish their role in regulatory toxicology.

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...